1. Introduction {#sec1-marinedrugs-14-00156}
===============

Marine microorganisms have been under the spotlight of scientists during the last decade due to their tremendous abilities of generating exceptional and potent natural products \[[@B1-marinedrugs-14-00156],[@B2-marinedrugs-14-00156]\]. In comparison to terrestrial environments, extreme marine environments bearing unique physico-chemical parameters such as high temperature, pressure, salinity or a deprivation from nutrition and dissolved oxygen gave rise to novel biologically active metabolites which can be further developed for the benefits of humanity \[[@B3-marinedrugs-14-00156]\]. It was proven that marine fungi can produce an assortment of secondary metabolites, protecting them from predators as well as acting as effective ways of communication between species \[[@B4-marinedrugs-14-00156],[@B5-marinedrugs-14-00156]\]. As a consequence, these adaptation strategies which enable the production of distinctive compounds with new chemical structures can exhibit substantial bioactivities against pathogens \[[@B6-marinedrugs-14-00156]\].

Verrucosidin, isolated from *Penicillium verrucosum* var. *cyclopium* \[[@B7-marinedrugs-14-00156],[@B8-marinedrugs-14-00156],[@B9-marinedrugs-14-00156],[@B10-marinedrugs-14-00156]\], was regarded as a powerful neurotoxin (LD~50~ in mice, 4 mg/kg, i.p.). It is considered as a down-regulator of the *grp*78 gene leading to selective cell death under low glucose levels \[[@B11-marinedrugs-14-00156]\]. In this study, an unusual conformational isomer of verrucosidin backbone, methyl isoverrucosidinol (**1**) ([Figure 1](#marinedrugs-14-00156-f001){ref-type="fig"}), was isolated from the fermentation of the hydrothermal vent fungi, *Penicillium* sp. Y-50-10. This paper describes the isolation, structure elucidation as well as the bioactivity of the isolated compound from that particular hydrothermal vent fungus.

2. Results {#sec2-marinedrugs-14-00156}
==========

The MeOH extracts of the mycelia and the EtOAc extracts of broth were subjected to repeated column chromatography to purify compound **1**.

Methyl isoverrucosidinol (**1**) was obtained as light yellow oil. The molecular formula C~25~H~36~O~7~ was determined by analysis of the HR-TOF-MS data ([Figure S8](#app1-marinedrugs-14-00156){ref-type="app"}). The formula was supported by the ^13^C-NMR data, which indicated 11 degrees of unsaturation. The NMR data ([Table 1](#marinedrugs-14-00156-t001){ref-type="table"}, [Figures S1--S7](#app1-marinedrugs-14-00156){ref-type="app"}) of compound **1** were similar to those of α-pyrone-type polyketides, verrucosidinols analogues \[[@B12-marinedrugs-14-00156],[@B13-marinedrugs-14-00156]\]. These molecules contain two distinct domains, a dicyclic 3,6-dioxabicyclo\[3.1.0\]hexane and a α-pyrone ring, connected by a olefinic chain \[[@B12-marinedrugs-14-00156],[@B13-marinedrugs-14-00156]\]. The ^13^C NMR spectrum showed the presence of eight signals for the α-pyrone ring domain including a 2*H*-pyran-2-one basic skeleton and two methyls and a methoxyl, and seven signals for dicyclic fused rings including a 3,6-dioxabicyclo\[3.1.0\]hexane skeleton and three methys, with the remaining nine resonances corresponding to an olefinic chain moiety. Fungal derived α-pyrone-type polyketides comprise mainly of two groups, verrucosidinol analogues \[[@B12-marinedrugs-14-00156],[@B13-marinedrugs-14-00156]\] and aurovertin analogues \[[@B14-marinedrugs-14-00156]\]. The main difference between these two skeletons lies at three methyls on the olefinic chain for the verrucosidinol skeleton, whereas the olefinic chain in aurovertin skeleton possesses no methyl group. When compared to the NMR data of the polyketide verrucosidinol \[[@B12-marinedrugs-14-00156],[@B13-marinedrugs-14-00156]\], compound **1** showed similar chemical shifts of the two main substructural domains. The presence of the characteristic ^13^C NMR methyl signals at δ~C~ 22.1, 13.3 and 17.6 on the olefinic chain ruled out the possibility of the presence of the aurovertin skeleton. However, according to the NMR data, the substructure of the olefinic chain was less similar to verrucosidinol. In order to elucidate the planar structure of the new compound, detailed 1 D and 2 D NMR experiments were carried out. The ^13^C NMR chemical shifts of five downfield signals C-1 (δ~C~ 166.0), C-2 (δ~C~ 109.4), C-3 (δ~C~ 170.4), C-4 (δ~C~ 112.3) and C-5 (δ~C~ 160.5) were in close agreement to those for an α-pyrone unit. The quartet methine protons of H-15 (δ~H~ 4.05, *J* = 6.8 Hz), the doublet methyl protons of H-23 (δ~H~ 1.18, *J* = 6.8 Hz), and the ^1^H--^1^H COSY signal ([Figure 2](#marinedrugs-14-00156-f002){ref-type="fig"}) between them suggested a connection between C-15 and C-23. The correlations from the methyl protons of H-23 to C-14 (δ~C~ 67.4) and C-15 (δ~C~ 76.9), from the methine proton of H-15 (δ~H~ 4.05) to C-12 (δ~C~ 80.0) and C-13 (δ~C~ 67.3), from the methyl protons of H-22 (δ~H~ 1.47) to C-14 and C-15, from the methine proton H-13 (δ~H~ 3.55) to C-12, thereby establishing the existence of a tetrahydrofuran ring moiety in **1**. The HMBC correlations from the methyl protons of H-18 (δ~H~ 1.45) to C-6 (δ~C~ 78.7) and C-5 (δ~C~ 160.5), from the methine proton of H-7 (δ~H~ 3.91) to C-6, C-8 (δ~C~ 132.7), C-18 (δ~C~ 22.1) and C-19 (δ~C~ 13.3), from the methyl protons H-19 (δ~H~ 1.79) to C-8, from the methine proton H-9 (δ~H~ 5.77) to C-7, C-19, and C-11 (δ~C~ 132.0), from the methyl protons H-20 (δ~H~ 1.89) to C-10 (δ~C~ 135.1), from the methine proton of H-11 (δ~H~ 5.45) to C-20 (δ~C~ 17.6), C-12 (δ~C~ 80.0) and C-13 (δ~C~ 67.3), from the methyl protons H-21 (δ~H~ 1.37) to C-12 completed the assignment of a heptadiene moiety. The ^1^H--^1^H COSY revealed correlations from H-9 to H-19, from H-9 to H-20 and from H-20 to H-11, which confirmed this deduction. The methoxy group was deduced to be attached to C-7, which was inferred from the cross peak between H-25 (δ~H~ 3.25) and C-7 in the HMBC spectrum of **1** ([Figure 2](#marinedrugs-14-00156-f002){ref-type="fig"}). The HMBC correlations from methine proton of H-7 to C-5 and from the methyl protons H-18 to C-5 revealed linkage between the heptadiene moiety and the α-pyrone moiety. The long range correlation cross peak from the methine proton H-11 to C-12 and C-13 connected the heptadiene moiety and the tetrahydrofuran ring moiety. From the above analysis, the planar structure of **1** was elucidated as a methylated derivative of verrucosidinol drawn in [Figure 1](#marinedrugs-14-00156-f001){ref-type="fig"}. The geometry of C~8~=C~9~ and C~10~=C~11~ were confirmed to be *E* by the analysis of NOE observation. The NOESY enhancements between H-11 and H-13, H-13 and H-22, and H-11 and H-23 supported the orientations of these groups in tetrahydrofuran ring ([Figure 2](#marinedrugs-14-00156-f002){ref-type="fig"}), showing the same results as verrucosidinol in literature \[[@B12-marinedrugs-14-00156],[@B13-marinedrugs-14-00156]\]. The NOESY enhancements between H-7 and H-17, H-18, H-9, and the weak enhancement between H-18 and H-9 determined their steric configuration respectively as shown in [Figure 2](#marinedrugs-14-00156-f002){ref-type="fig"}. Since the rotation of C-7 was hindered by the contact of pyran-2-one and the OH or OMe at C-7, the relative configuration of C-7 was achieved with NOESY experiments by Lixin Zhang's groups \[[@B12-marinedrugs-14-00156]\]. The results in this study confirmed the relative configuration of C-7 ([Figure 2](#marinedrugs-14-00156-f002){ref-type="fig"}).

However, key NOESY enhancements between H-9 and Me-20, H-11 and Me-19, allowed the assignment of a new conformational isomerization between double bond C~8~=C~9~ and C~10~=C~11~. This is the first example of discovering such an unusual conformational isomer of verrucosidin skeleton.

How is the new conformation of C~8~=C~9~--C~10~=C~11~ immobilized? Although these two isomers have a same C=C--C=C architecture, there exists a basic difference, which is the steric location of Me-19 and Me-20.

It is known that the methyl group is not bulky enough to suppress the rotation of the single bond in the olefin chain. However, the principal barriers to rotation about the olefin chain in compound **1** are the substituent bulky ring system attached on each side of the C~8~=C~9~--C~10~=C~11~, which formed a U shape of molecule ([Figure 2](#marinedrugs-14-00156-f002){ref-type="fig"}). Obviously, close contacts occur with two ring systems of 2*H*-pyran-2-one and dicyclic fused 3,6-dioxabicyclo\[3.1.0\]hexane, preventing the free rotation. The structures, therefore, fall into two classes: those in which the Me-19, Me-20 are on one side and those which are on different side. As far as the steric effect on rotation is concerned, the close contacts make the existence of two isomers and make it extremely unlikely that two isomers transform in ordinary condition.

In order to confirm the stability of the conformation, rotation barrier was calculated by Gaussian 09 scan program. 13 different transition states were calculated by different dihedrals between C~8~=C~9~ and C~10~=C~11~ from −166° to 80°. Configuration optimizations were done by employing density functional theory (DFT) B3LYP method ([Tables S1 and S2](#app1-marinedrugs-14-00156){ref-type="app"}). Same combined basis set was used, in which C, H and O atoms were described by 6-31+G(d,p) basis set. Frequency analysis was done at the same level of theory to verify that these optimized structures are real minima on the potential energy surface. The calculated results were elucidated as drawn in [Figure 3](#marinedrugs-14-00156-f003){ref-type="fig"}. It was shown that two low-lying isomers are normal verrucosidin skeleton (0 kJ/mol) and compound **1** (10 kJ/mol), the high rotation barrier of at least 68 kJ/mol between two low-lying isomers prove that two conformational isomers could not transform spontaneously under room temperature ([Figure 3](#marinedrugs-14-00156-f003){ref-type="fig"}). The remaining isomers are either kinetically unstable with low barriers or energetically very high lying.

The absolute configurations of **1** were determined by simulation of the ECD spectrum. The minimum energy geometries of two conformers were optimized using DFT at the B3LYP/6-31+G(d,p) level in the gas phase by the GAUSSIAN 09. Then the ECD spectra Calculation were simulated using the time-dependent density functional theory (TDDFT) employing the B3LYP functional at the B3LYP/6-31+G(d,p) level in methanol. The calculated ECD curves were drawn by using SpecDis with a σ of 0.25 eV ([Figure S9](#app1-marinedrugs-14-00156){ref-type="app"}). The calculated ECD spectrum for 6*S*,7*S*,12*S*,13*S*,14*R*,15*R* showed a negative Cotton effect at 250 nm and a positive Cotton effect at 300 nm which is identical to the experimental ECD spectra. Therefore, the absolute configurations of **1** were determined as 6*S*,7*S*,12*S*,13*S*,14*R*,15*R* ([Figure 4](#marinedrugs-14-00156-f004){ref-type="fig"}). Compound **1** was named as methyl isoverrucosidinol.

In order to rule out the possibility that the methoxy originated from the methanol used in the extraction or methanol/silica in the purification, a small scale experiment was conducted. *Penicillium* sp. Y-50-10 was cultured under static conditions in Erlenmeyer flasks for one week. The medium was extracted with EtOAc. The EtOAc extract was evaporated and dissolved in acetonitrile. The MS result showed that compound **1** presents without methanol in the extraction, purification and measurement ([Figure S10](#app1-marinedrugs-14-00156){ref-type="app"}).

Biological Activity
-------------------

The antibacterial activities of the isolated compound were evaluated against three terrestrial pathogenic bacteria, *Escherichia coli*, *Staphylococcus aureus* and *Bacillus subtilis*. Compound **1** exhibited weak antibiotic activity with MIC values of around 32 μg/mL against *B. subtilis*. However, the MIC values of the compound obtained against *E. coli* and *S. aureus* were greater than 64 μg/mL and thus were considered as "negligible activity". Tetracycline was used as a positive control against *E. coli*, *S. aureus* and *B. subtilis* which showed MIC values of 2, 2, 1 μg/mL, respectively.

3. Materials and Methods {#sec3-marinedrugs-14-00156}
========================

3.1. General Experimental Procedures {#sec3dot1-marinedrugs-14-00156}
------------------------------------

Optical rotations were measured in MeOH on a Perkin-Elmer-341 polarimeter. The IR spectra were run on a NicoletAvatar-360FT-IR spectrometer. ^1^H NMR (500 MHz) and ^13^C NMR (125 MHz) spectra were measured at 25 °C on a Bruker AVANCE DMX 500 NMR spectrometer with TMS as internal standard. CD spectra were measured on a JASCO J-715 (JASCO) spectropolarimeter. UV spectra were also recorded in MeOH on a Shimadzu UV2550. ESIMS were recorded on an Agilent 6460 Triple Quad LCMS. Prep. HPLC was performed on a ChuangXinTongHeng system equipped with a Venusil MP-C18 column (10 mm × 250 mm, Agela Technologies, Tianjin, China).

3.2. Isolation and Cultivation of the Fungal Strain {#sec3dot2-marinedrugs-14-00156}
---------------------------------------------------

*Penicillium* sp. Y-50-10 was isolated from the Sulfur rich sediment, Kueishantao, Taiwan in May 2014. The fungus was cultured under static conditions at 28 °C in 500 mL Erlenmeyer flasks containing 200 mL of liquid culture medium composed of glucose (10.0 g/L), potato dextrose agar (PDA) (20.0 g/L), and seawater. After 3 weeks of cultivation, 5 L of whole broth was filtered to separate the thallus. After fermentation, the medium was extracted with EtOAc. The fungus was classified as *Penicillium* sp. on the basis of the ITS 18S fragment.

3.3. Extraction and Isolation {#sec3dot3-marinedrugs-14-00156}
-----------------------------

5 L of the fungal culture broth was filtered. The air-dried thallus part was extracted at room temperature with MeOH. The residues were dissolved in H~2~O (250 mL) and extracted with EtOAc (3 × 500 mL). The broth (5 L) was extracted with EtOAc (2 × 5 L). Both were combined and concentrated to give an organic extract (0.69 g). The extract was subjected to liquid chromatography over a silica gel column using a gradient elution of petroleum ether (PE)--EtOAc--MeOH (PE:EtOAc = 1:0, 20:1, 10:1, 5:1, 2:1, 1:1, 0:1 & MeOH) to give several fractions. Seven main fractions were obtained which was confirmed by TLC. Every fraction was dissolved in methanol and centrifuged at 12,000 rpm for 10 min. The supernatant was collected and subjected to preparative HPLC (10.0 mL/min, UV = 210 nm), using MeOH:H~2~O as eluent. Fraction 4 was separated by preparative HPLC (MeOH:H~2~O = 50:50, 10 mL/min) to afford compound **1** (1.4 mg, t~R~ 26.0 min).

3.4. Computation Section {#sec3dot4-marinedrugs-14-00156}
------------------------

The geometry was optimized starting from initial conformations, with DFT calculations at the B3LYP/6-31+G(d,p) level using the Gaussian09 program. Time-dependent DFT calculations were performed on the lowest-energy conformations for each configuration using 30 excited states and under the CH~3~OH solution. ECD spectra were generated using the program SpecDis by applying a Gaussian band shape with 0.3 eV width, from dipole-length rotational strengths \[[@B15-marinedrugs-14-00156],[@B16-marinedrugs-14-00156]\].

Methyl isoverrucosidinol (**1**): light yellow oil; $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{20}$ −1.23 (*c* 0.1, CH~3~OH); UV/vis (CH~3~OH) λ~max~ (logε) 200 (4.23), 232 (3.95), 297 (3.69); IR ν~max~ 3415, 2917, 2849, 1700, 1684, 1559, 1457, 1379, 1352, and 1090 cm^−1^; CD (c 4.5 × 10^−4^ mol/L, CH~3~OH) λ~max~ (Δε): 214 (−48.5), 236 (−63.5), 295 (−28.8), 340 (−0.3); ^1^H and ^13^C NMR, [Table 1](#marinedrugs-14-00156-t001){ref-type="table"}.; HRESIMS *m*/*z* 449.2544 \[M + H\]^+^ (calcd. for C~25~H~37~O~7~^+^, 449.2539).

3.5. Biological Assays {#sec3dot5-marinedrugs-14-00156}
----------------------

Antibacterial activities were evaluated by the conventional broth dilution assay \[[@B17-marinedrugs-14-00156]\]. Three bacterial strains, *E. coli* \[CMCC (B) 44102\], *S. aureus* \[CMCC (B) 26003\], *B. subtilis* \[CMCC (B) 63501\], were used, and tetracycline was used as positive control.

4. Conclusions {#sec4-marinedrugs-14-00156}
==============

Due to the duplication in the isolation of secondary metabolites from terrestrial sources, the marine world can be considered as the sole source of novel compounds with beneficial applications in the medical sector. Among hitherto known compounds with a verrucosidine backbone found in nature, methyl isoverrucosidinol (**1**) represents the first example of a new conformational isomer of its skeleton. The relationship between conformation and bioactivity of natural products is worth exploring further. This study also proved that marine microorganisms, especially the ones thriving in extreme conditions have the capacities of generating new and unique natural products. Therefore, more work should be done in order to discover novel potent bioactive compounds which could further unveil the secrets of combatting infectious diseases forever.
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###### 

^1^H NMR data (500 MHz, δ in ppm, *J* in Hz), ^13^C NMR data (125 MHz, δ in ppm) and for **1**. Taken in CD~3~OD.

  Carbon Number   δ~C~, Type ^a^   δ~H~ (*J* in Hz)   Carbon Number   δ~C~, Type ^a^   δ~H~ (*J* in Hz)
  --------------- ---------------- ------------------ --------------- ---------------- ------------------
  1               166.0, C                            14              67.4, C          
  2               109.4, C                            15              76.9, CH         4.05, q (6.8)
  3               170.4, C                            16              8.9, CH~3~       2.00, s
  4               112.3, C                            17              8.8, CH~3~       2.25, s
  5               160.5, C                            18              22.1, CH~3~      1.45, s
  6               78.7, C                             19              13.3, CH~3~      1.79, s
  7               90.6, CH         3.91, s            20              17.6, CH~3~      1.89, s
  8               132.7, C                            21              20.8, CH~3~      1.37, s
  9               135.3, CH        5.77, s            22              12.5, CH~3~      1.47, s
  10              135.1, C                            23              17.8, CH~3~      1.18, d (6.8)
  11              132.0, CH        5.45, s            24              59.7, CH~3~      3.84, s
  12              80.0, C                             25              55.7, CH~3~      3.25, s
  13              67.3, CH         3.55, s                                             

^a^ Multiplicities inferred from DEPT and HMQC experiments.
